Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin as adjunctive treatment in hospitalized adults with COVID-19
IRCT20200413047062N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of atorvastatin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Clinical response, Laboratory response and 3 more. Started Apr 2020; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200413047062N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200413047062N1.